Skip to main content

Table 5 Drug Resistance of Gram-Positive Bacteria

From: Drug resistance and influencing factors of biofilm bacteria in upper urinary calculi patients with double J stent indwelling

Antibacterial Drugs

Double J-Stent

Biofilm Bacteria

Urine

Pathogenic Bacteria

Double J-Stent Pathogenic Bacteria

Pa

Pb

Strain(62)

Ratio(%)

Strain(37)

ratio(%)

Strain(46)

ratio(%)

Linezolid

6

9.7

0

0

0

0

0.050

0.029

Vancomycin

1

1.6

0

0

1

2.1

0.437

0.830

Tigecycline

2

3.2

0

0

0

0

0.269

0.218

Rifampicin

10

16.1

4

10.8

6

13.0

0.462

0.655

Nitrofurantoin

19

30.6

6

16.2

8

17.4

0.109

0.115

Cotrimoxazole

18

29.0

8

21.6

11

23.9

0.417

0.552

Moxifloxacin

30

48.4

10

27.0

12

26.0

0.036

0.018

Quinopltin/dafopltin

20

32.2

11

29.7

14

30.4

0.792

0.839

Levofloxacin

40

64.5

13

35.1

14

30.4

0.004

<0.001

Tetracycline

33

53.2

17

45.9

19

41.3

0.483

0.220

Ciprofloxacin

34

54.8

18

48.6

22

47.8

0.550

0.470

HGEN

19

30.6

9

24.3

12

26.0

0.499

0.604

Gentamicin

30

48.3

18

48.6

20

43.3

0.974

0.612

HLSR

13

20.9

7

18.9

11

23.9

0.806

0.715

Ampicillin

50

80.6

20

54.0

24

52.1

0.004

0.001

Penicillin G

51

82.2

22

59.4

25

54.3

0.012

0.001

Ampicillin/sulbactam

40

64.5

20

54.0

23

50.0

0.302

0.130

Amoxicillin/clavulanic acid

39

62.9

22

59.4

24

52.1

0.733

0.263

Oxacillin

47

75.8

21

56.7

23

50.0

0.048

0.005

Ceftriaxone

46

74.2

20

54.0

23

50.0

0.039

0.009

  1. Pa: Comparison of drug resistance of double J-stent biofilm bacteria and urine pathogenic bacteria; Pb: Comparison of drug resistance of double J-stent biofilm bacteria and double J-stent pathogenic bacteria